News

Brand-drug costs rising faster than inflation


 

The cost of brand drugs increased 12.5% last year, far outpacing inflation overall, Express Scripts said in its annual Drug Trend Report.

The overall U.S. inflation rate, according to the Bureau of Labor Statistics, was only 1.7% in 2012.

From January 2008 to December 2012, the cost of an "unchanged market basket of brand drugs rose from $100 to $165.44," Express Scripts said in the report, while the Consumer Price Index, which measures a broad selection of goods and services, went from $100 to $108.80.

The cost of an unchanged selection of generic drugs did the opposite over the same 5-year period, dropping to $57.38 by the end of 2012, according to the report. All dollar values have been adjusted to 2008 dollars.

In 2012 alone, the cost of generic drugs dropped by 24.4%, following decreases of 3.7% in 2011, 14.7% in 2010, and 0.5% in 2009. The price of brand drugs rose 13.6% in 2011, 9.6% in 2010, and 9.1% in 2009, the report noted.

rfranki@frontlinemedcom.com

Recommended Reading

Technology transforming the practice of psychiatry
MDedge Psychiatry
Start older patients with GAD on medication early
MDedge Psychiatry
Emergency physicians share lessons from Boston Marathon bombings response
MDedge Psychiatry
Lawmakers take aim at ACA implementation: The Policy & Practice podcast
MDedge Psychiatry
Supreme Court ponders patenting of human genes
MDedge Psychiatry
Navigating the new insurance exchanges
MDedge Psychiatry
Make health a mobile game for youths
MDedge Psychiatry
U.S. Cymbalta cost highest in international comparison
MDedge Psychiatry
ACA still not reducing ranks of uninsured
MDedge Psychiatry
Know your values to achieve professional balance
MDedge Psychiatry